Daron Evans - 24 May 2021 Form 4/A - Amendment Insider Report for NEPHROS INC (NEPH)

Role: CEO Specialty Renal Products
Signature: /s/ Daron Evans
Issuer symbol: NEPH
Transactions as of: 24 May 2021
Net transactions value: -$1,885
Form type: 4/A - Amendment
Filing time: 01 Jun 2021, 17:39:58 UTC
Date Of Original Report: 25 May 2021
Next filing: 25 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEPH	Common Stock	Tax liability	$942	-349	-3.8%	$2.70	8,947	27 May 2021	By UTMA #1
transaction	NEPH	Common Stock	Tax liability	$942	-349	-3.9%	$2.70	8,669	27 May 2021	By UTMA #2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This amendment is being filed solely to report the unintentional omission of the withholding of shares otherwise to be issued to each of UTMA #1 and UTMA #2 in connection with the previously reported cashless warrant exercises.